The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
about
Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosisOrigin and proliferation of multiple-drug resistance in bacterial pathogensThe molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosisThe stringent response of Mycobacterium tuberculosis is required for long-term survivalExposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: implications for chemotherapy against mycobacterial persistorsRv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.Individual Mycobacterium tuberculosis universal stress protein homologues are dispensable in vitro.Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammationSterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis.Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.Surviving the acid test: responses of gram-positive bacteria to low pH.Current development and future prospects in chemotherapy of tuberculosisDormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in micePopulation pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorptionDrug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria.Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis.Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis.Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
P2860
Q24796366-C0D885D8-14A1-4151-941A-F479405A7168Q27023284-E06ED056-D903-4EB4-B36A-4AB275D84A8AQ28362898-A26E1FA8-B6DB-4E68-B887-0E5E523CE992Q28486427-1A8C0729-5291-49DE-A298-EC9367AAEA08Q28487060-B367872B-A003-4363-85BB-5372B5FAF0B5Q28487067-C8C34018-4A6F-4F43-95BC-121909D00CAFQ33678888-9FEAA1B8-A70F-47B9-BFB4-E5223A20F241Q33805878-17D23397-2CAF-4E19-A946-84AAFE1F3D25Q34037486-9AEC18BF-2657-43FE-93AD-464FD68EEB53Q34768240-1C653EBF-270A-4AB5-ABED-0E8456BF3989Q34823019-59A13DD6-9185-4B50-9A1F-D9127A763701Q34973845-83198E0A-2BD0-485B-97D4-CD6C420210B1Q34974987-46F43065-A45F-494A-B1A6-CBFB21B031D7Q35215950-6098F158-CA3A-4B71-854E-8E4A3BCE752AQ35705874-170EBF81-02AB-421E-A006-EFDBB553B8A3Q36402431-D86D10DB-F06B-42A1-BD83-79BCCA255F48Q36702972-CAFFFE1F-6647-4744-A60F-ED6982B16A62Q37194295-0CA484F5-A4B9-457C-BF25-7EC47F6C8062Q37343752-8B93E17E-EB25-443E-B9F5-1F013A03A1BCQ39446208-4BF39472-81C8-4986-8A71-20DD4FE4DB66Q39557385-CAD32641-58CA-48E1-9425-E76DB316218DQ39782912-DFD39DEA-D092-4540-8E53-FAC0039DB7EC
P2860
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
@ast
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
@en
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
@nl
type
label
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
@ast
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
@en
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
@nl
prefLabel
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
@ast
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
@en
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
@nl
P1476
The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems
@en
P2093
D A Mitchison
P304
P407
P577
1992-05-01T00:00:00Z